1. Home
  2. SGLY vs NLSP Comparison

SGLY vs NLSP Comparison

Compare SGLY & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGLY
  • NLSP
  • Stock Information
  • Founded
  • SGLY 2001
  • NLSP 2015
  • Country
  • SGLY United States
  • NLSP Switzerland
  • Employees
  • SGLY N/A
  • NLSP N/A
  • Industry
  • SGLY
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • SGLY
  • NLSP Health Care
  • Exchange
  • SGLY Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • SGLY 5.8M
  • NLSP 5.2M
  • IPO Year
  • SGLY 2008
  • NLSP 2021
  • Fundamental
  • Price
  • SGLY $1.55
  • NLSP $1.95
  • Analyst Decision
  • SGLY
  • NLSP
  • Analyst Count
  • SGLY 0
  • NLSP 0
  • Target Price
  • SGLY N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • SGLY 14.2K
  • NLSP 535.3K
  • Earning Date
  • SGLY 11-14-2024
  • NLSP 12-31-2024
  • Dividend Yield
  • SGLY N/A
  • NLSP N/A
  • EPS Growth
  • SGLY N/A
  • NLSP N/A
  • EPS
  • SGLY N/A
  • NLSP N/A
  • Revenue
  • SGLY $2,742,157.00
  • NLSP N/A
  • Revenue This Year
  • SGLY N/A
  • NLSP N/A
  • Revenue Next Year
  • SGLY N/A
  • NLSP N/A
  • P/E Ratio
  • SGLY N/A
  • NLSP N/A
  • Revenue Growth
  • SGLY N/A
  • NLSP N/A
  • 52 Week Low
  • SGLY $1.27
  • NLSP $1.73
  • 52 Week High
  • SGLY $7.65
  • NLSP $24.32
  • Technical
  • Relative Strength Index (RSI)
  • SGLY 43.10
  • NLSP 34.15
  • Support Level
  • SGLY $1.58
  • NLSP $1.73
  • Resistance Level
  • SGLY $1.71
  • NLSP $2.79
  • Average True Range (ATR)
  • SGLY 0.09
  • NLSP 0.36
  • MACD
  • SGLY -0.00
  • NLSP 0.04
  • Stochastic Oscillator
  • SGLY 35.71
  • NLSP 14.67

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: